These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 35237178)
1. Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway. Wang T; Zhang C; Meng X; Zhu B; Wang S; Yuan W; Zhang S; Xu J; Zhang C Front Physiol; 2022; 13():792182. PubMed ID: 35237178 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of serum extracellular vesicles in liver fibrosis. Chen L; Chen R; Kemper S; Cong M; You H; Brigstock DR J Extracell Vesicles; 2018; 7(1):1461505. PubMed ID: 29696080 [TBL] [Abstract][Full Text] [Related]
3. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite. Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886 [TBL] [Abstract][Full Text] [Related]
4. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype. Chiabotto G; Ceccotti E; Tapparo M; Camussi G; Bruno S Front Cell Dev Biol; 2021; 9():777462. PubMed ID: 34796180 [TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810 [TBL] [Abstract][Full Text] [Related]
6. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis. Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418 [TBL] [Abstract][Full Text] [Related]
7. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1. Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MALAT1 as a ceRNA drives mouse fibroblast activation via the miR-335-3p/P2ry2 axis. Chen M; Peng J; Zhu G; Qian C; Xiao Z; Song X; Yu H; Huang R; Wang W; Zheng H; Yu Y PLoS One; 2024; 19(8):e0308723. PubMed ID: 39133718 [TBL] [Abstract][Full Text] [Related]
10. Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway. Hu J; Liu Y; Pan Z; Huang X; Wang J; Cao W; Chen Z Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983006 [TBL] [Abstract][Full Text] [Related]
11. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells. Shi Z; Zhang K; Chen T; Zhang Y; Du X; Zhao Y; Shao S; Zheng L; Han T; Hong W Cell Death Dis; 2020 Dec; 11(12):1066. PubMed ID: 33311456 [TBL] [Abstract][Full Text] [Related]
13. Human Liver Stem Cell Derived Extracellular Vesicles Alleviate Kidney Fibrosis by Interfering with the β-Catenin Pathway through miR29b. Kholia S; Herrera Sanchez MB; Deregibus MC; Sassoè-Pognetto M; Camussi G; Brizzi MF Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639119 [TBL] [Abstract][Full Text] [Related]
14. MALAT1 promotes liver fibrosis by sponging miR‑181a and activating TLR4‑NF‑κB signaling. Wang Y; Mou Q; Zhu Z; Zhao L; Zhu L Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34651657 [TBL] [Abstract][Full Text] [Related]
15. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a. Yu F; Fan X; Chen B; Dong P; Zheng J Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641 [TBL] [Abstract][Full Text] [Related]
16. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214 [TBL] [Abstract][Full Text] [Related]
17. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
18. MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis. Yu F; Lu Z; Cai J; Huang K; Chen B; Li G; Dong P; Zheng J Cell Cycle; 2015; 14(24):3885-96. PubMed ID: 26697839 [TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice. Gong Q; Zeng Z; Jiang T; Bai X; Pu C; Hao Y; Guo Y Front Nutr; 2022; 9():1009139. PubMed ID: 36276815 [TBL] [Abstract][Full Text] [Related]